Mark Sheptoff Financial Planning LLC Acquires Shares of 2,200 Hinge Health Inc. $HNGE

Mark Sheptoff Financial Planning LLC bought a new position in Hinge Health Inc. (NYSE:HNGE) in the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 2,200 shares of the company’s stock, valued at approximately $114,000.

Several other hedge funds also recently made changes to their positions in HNGE. Strategic Blueprint LLC bought a new position in Hinge Health in the second quarter worth $346,000. FNY Investment Advisers LLC bought a new stake in shares of Hinge Health during the 2nd quarter valued at $310,000. CHURCHILL MANAGEMENT Corp purchased a new stake in shares of Hinge Health in the 2nd quarter worth about $828,000. Finally, Emerald Advisers LLC bought a new position in shares of Hinge Health in the 2nd quarter worth about $108,000.

Hinge Health Stock Up 0.9%

NYSE:HNGE opened at $44.43 on Friday. Hinge Health Inc. has a 12 month low of $33.42 and a 12 month high of $62.18. The stock has a 50 day moving average of $52.43.

Hinge Health (NYSE:HNGE) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The firm had revenue of $154.21 million for the quarter, compared to the consensus estimate of $142.44 million. The business’s quarterly revenue was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on HNGE shares. Bank of America boosted their price objective on shares of Hinge Health from $42.00 to $64.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Barclays lifted their price objective on Hinge Health from $62.00 to $65.00 and gave the company an “overweight” rating in a research note on Wednesday. Wall Street Zen upgraded Hinge Health from a “hold” rating to a “buy” rating in a report on Saturday. Citigroup began coverage on shares of Hinge Health in a research note on Monday, July 14th. They issued an “outperform” rating on the stock. Finally, JMP Securities upped their target price on shares of Hinge Health from $58.00 to $65.00 and gave the stock a “market outperform” rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $59.93.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.